The approval of Epidiolex "serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies - Sarah Jacoby


image by: Rebecca Bailey Roten

HWN Recommends

The first FDA-approved cannabis-derived drug is available for prescription in the US

Epidiolex contains cannabidiol—the chemical compound also known as CBD—which is increasingly popular for its reported abilities to deliver relief from maladies such as anxiety, joint pain, insomnia, and nausea. And while Epidiolex is approved specifically for treating two potentially fatal forms of severe childhood epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, there’s a good chance it will be prescribed for “off-label” use.

“The off-label use of CBD and Epidiolex will be a fascinating subject to look at over the coming years,” Orrin Devinsky, the director of the Comprehensive Epilepsy Center at NYU Langone Health and the lead investigator of two clinical trials of Epidiolex,…

read full article


Related Articles

Stay Connected

©2022 | HealthWorldNet, Inc. | 116501

Last Updated : Sunday, March 13, 2022